C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
195/1.22, 195/1.
C12N 9/72 (2006.01) A61K 38/49 (2006.01) C12N 15/12 (2006.01) C12N 15/66 (2006.01) A61K 38/00 (2006.01)
Patent
CA 1341447
Tissue plasminogen activator analogs exhibiting greater specificity for fibrin than native t-PA are disclosed. The analogs include the K1 domain of native t-PA replaced with another kringle domain mediating the binding of the analog to fibrin. The kringle contains six cysteine residues. The t-PA analogs may further include a variety of substitutions and modifications. Pharmaceutical compositions containing one or more of the t-PA analogs along with a physiologically acceptable carrier or diluent are also disclosed.
568719
Hashimoto Akira
Ikeda Yasunori
Mulvihill Eileen R.
Nexo Bjorn A.
Suzuki Suguru
Eisai Co. Ltd.
Mccarthy Tetrault Llp
Novo Industri A/s
Novo Nordisk A/s
Zymogenetics Inc.
LandOfFree
Mutant t-pa with kringle replacement does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Mutant t-pa with kringle replacement, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mutant t-pa with kringle replacement will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1315512